BRIDGEBIO PHARMA INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in BRIDGEBIO PHARMA INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$212.4M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity2 increased1 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CAPSTONE INVESTMENT ADVISORS, LLC CIK 0001426196 | Hedge Fund | 69.87M | $124.5M | 58.6% | 0.2% | Added | +$27.6M | Q2 2026 |
| MOORE CAPITAL MANAGEMENT, LP CIK 0001448574 | Hedge Fund | 31.93M | $56.9M | 26.8% | 0.8% | Added | — | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 17.14M | $30.5M | 14.4% | 0.0% | Reduced | $-13.4M | Q2 2026 |
| GAMCO INVESTORS, INC. ET AL CIK 0000807249 | Institutional Manager | 300K | $536K | 0.3% | 0.0% | Unchanged | +$0 | Q2 2026 |
Added
Hedge Fund
$124.5M· 58.6% of total· 0.2% port· 69.87M sh· +$27.6M QoQ· Q2 2026
Added
Hedge Fund
$56.9M· 26.8% of total· 0.8% port· 31.93M sh· — QoQ· Q2 2026
Reduced
Hedge Fund
$30.5M· 14.4% of total· 0.0% port· 17.14M sh· $-13.4M QoQ· Q2 2026
Unchanged
Institutional Manager
$536K· 0.3% of total· 0.0% port· 300K sh· +$0 QoQ· Q2 2026